Well, I think you're absolutely right; we would agree with that. I think there's probably too much expectation laid at the door of the pharmaceutical industry in terms of solving these problems. I would agree with you entirely that government really has to step up to the plate.
There's been adequate research done; there are a variety of methodologies being developed in order to do this. New technologies will enable it even further. It does require a substantial piece of work, and that's why the amount of money we're recommending is fairly substantial.
But I would agree with you entirely. Government has to step up to the plate, has to fund these programs and has to give direction. The recognition is that there does need to be an emphasis on post-marketing surveillance. The work on pre-market approval has clearly been shown to be inadequate.